176 related articles for article (PubMed ID: 36185186)
1. Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity.
Qu R; Tu D; Cai Y; Ping W; Fu X
Front Oncol; 2022; 12():979522. PubMed ID: 36185186
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognosis of ground-glass opacity nodules in young patients.
Wang J; Ma H; Ni CJ; He JK; Ma HT; Ge JF
J Thorac Dis; 2019 Feb; 11(2):557-563. PubMed ID: 30963000
[TBL] [Abstract][Full Text] [Related]
3. Distinct cellular immune profiles in lung adenocarcinoma manifesting as pure ground glass opacity versus solid nodules.
Qu R; Ye F; Hu S; Wang B; Qin S; Xiong J; Fu X; Li L; Cai Y
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3775-3788. PubMed ID: 35986758
[TBL] [Abstract][Full Text] [Related]
4. Ground glass opacity resection extent assessment trial
Li H; Wang Y; Chen Y; Zhong C; Fang W
Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
[TBL] [Abstract][Full Text] [Related]
5. Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study.
Xu SJ; Chen RQ; Tu JH; You CX; Chen C; Zhang ZF; Divisi D; Migliore M; Bongiolatti S; Durand M; Sato M; Kuroda H; Yang CF; Yu SB; Chen SC
Transl Lung Cancer Res; 2023 May; 12(5):1078-1092. PubMed ID: 37323166
[TBL] [Abstract][Full Text] [Related]
6. Recurrence Patterns and Patient Outcomes in Resected Lung Adenocarcinoma Differ according to Ground-Glass Opacity at CT.
Park S; Lee SM; Choe J; Choi S; Do KH; Seo JB
Radiology; 2023 May; 307(3):e222422. PubMed ID: 36943079
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma.
Zhai W; Liang D; Duan F; Wong W; Yan Q; Gong L; Lai R; Dai S; Long H; Wang J
Front Cell Dev Biol; 2021; 9():769881. PubMed ID: 34957101
[TBL] [Abstract][Full Text] [Related]
8. Primary lung cancer in children and adolescents.
Chen Q; Cheng J; Wang L; Lv X; Hu J
J Cancer Res Clin Oncol; 2024 May; 150(5):225. PubMed ID: 38695944
[TBL] [Abstract][Full Text] [Related]
9. Ground glass opacity featured lung adenocarcinoma in teenagers.
Wu H; Zhang Y; Hu H; Li Y; Shen X; Liu Q; Wang S; Chen H
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3719-3724. PubMed ID: 33829316
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.
Moon Y; Sung SW; Lee KY; Park JK
J Thorac Dis; 2016 Sep; 8(9):2562-2570. PubMed ID: 27747010
[TBL] [Abstract][Full Text] [Related]
11. Pathological and radiological T descriptors in invasive lung adenocarcinoma: from correlations to prognostic significance.
Ma Z; Han H; Cao H; Wang S; Li Y; Zhang Y; Chen H
Transl Lung Cancer Res; 2023 Nov; 12(11):2181-2192. PubMed ID: 38090517
[TBL] [Abstract][Full Text] [Related]
12. Should resection extent be decided by total lesion size or solid component size in ground glass opacity-containing lung adenocarcinomas?
Lin B; Wang R; Chen L; Gu Z; Ji C; Fang W
Transl Lung Cancer Res; 2021 Jun; 10(6):2487-2499. PubMed ID: 34295656
[TBL] [Abstract][Full Text] [Related]
13. Prognostic effect of ground-glass opacity in subcentimeter invasive lung adenocarcinoma.
Bai J; Fu F; Sun W; Deng C; Ma Z; Wang S; Deng L; Zhang Y; Chen H
J Thorac Dis; 2023 Apr; 15(4):1559-1571. PubMed ID: 37197537
[TBL] [Abstract][Full Text] [Related]
14. Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.
Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Tane K; Tsuboi M
J Thorac Oncol; 2018 Apr; 13(4):533-542. PubMed ID: 29246833
[TBL] [Abstract][Full Text] [Related]
15. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
[TBL] [Abstract][Full Text] [Related]
17. Distinct clinicopathologic factors and prognosis based on the presence of ground-glass opacity components in patients with resected stage I non-small cell lung cancer.
Wang C; Wu Y; Li J; Ren P; Gou Y; Shao J; Zhou Y; Xiao X; Tuersun P; Liu D; Zhang L; Li W
Ann Transl Med; 2020 Sep; 8(18):1133. PubMed ID: 33240982
[TBL] [Abstract][Full Text] [Related]
18. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
[TBL] [Abstract][Full Text] [Related]
19. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
Zhang Y; Fu F; Chen H
Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
[TBL] [Abstract][Full Text] [Related]
20. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
